Speaker Profile
David Dobnik

David Dobnik PhD

Biotechnology, Research and Clinical Research
Ljubljana, Osrednjeslovenska, Slovenia

Connect with the speaker?

David Dobnik, Ph.D. in biotechnology, has been working at the National Institute of Biology for thirteen years. His main focus area is the development of new nucleic acid detection/quantification approaches. From 2016 he has been closely working with companies in the field of gene therapy (including but not limited to AveXis (now Novartis Gene Therapies) and Axovant Gene Therapies) to develop and apply methods for precise quantification of viral vectors (e.g. ddPCR, qPCR), observation of viral particles (electron microscopy), and for identification and quantification of impurities (e.g. nucleic acids by high-throughput sequencing (HTS/NGS) or PCR-based methods, and other by electron microscopy). This way, the National Institute of Biology enables efficient development of up-and downstream processes of therapeutic virus production and performs tech transfer of new analytical methods.”
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)